Anastrozole
Indication
Primary prevention of breast cancer in postmenopausal women at moderate or high risk
Amber level 0
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Immune system and Malignant Disease
Background
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer https://www.nice.org.uk/guidance/cg164/chapter/Recommendations
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: